Skip to content

Japt.gr

Hellenic Atherosclerosis Society

HOME
ABOUT
- SCOPE
- EDITORIAL BOARD
CURRENT ISSUE
ARCHIVES
FOR AUTHORS
SUBMIT MANUSCRIPT
CONTACT

Menu

Search for:

Tag Archives: SGLT2 inhibitor

The use of dapagliflozin in the treatment of type 2 diabetes mellitus

Α. Liontos, E. Klouras, M. Florentin, E. Liberopoulos, M. Elisaf

Search for:

CURRENT ISSUE

Effect of treatment with sublingual vitamin B12 in patients with B12 deficiency

The nutritional value and health properties of tahini and tahini-based products

Lifelong psychological and lifestyle features in relation to cardiovascular disease development: A narrative review

Cardiovascular Disease in Women: A review of statements and positions

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (4) cardiovascular disease (27) cardiovascular diseases (6) Cardiovascular risk (6) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (4) diabetes mellitus (9) diet (6) dyslipidemia (14) empagliflozin (3) epidemiology (3) ezetimibe (5) Familial hypercholesterolemia (5) Heart failure (5) hypertension (9) inflammation (10) Ischemic stroke (3) Lipoprotein(a) (3) lipoproteins (4) Mediterranean diet (8) metabolic syndrome (7) morbidity (3) mortality (8) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (9) omega-3 fatty acids (3) outcome (3) PCSK9 (3) PCSK9 inhibitors (5) physical activity (4) platelets (8) smoking (3) statins (15) stroke (3) thrombin (3) thrombosis (4) treatment (6) type 2 diabetes mellitus (4)

Journal of Atherosclerosis Prevention and Treatment ©2024

A SiteOrigin Theme